These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2664736)
21. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Friedrich B; Grönberg H; Landström M; Gullberg M; Bergh A Prostate; 1995 Aug; 27(2):102-9. PubMed ID: 7638082 [TBL] [Abstract][Full Text] [Related]
22. Basal cells of H-Dunning tumor are myoepithelial cells. A comparative immunohistochemical and ultrastructural study with male accessory sex glands and mammary gland. Aumüller G; Gröschel-Stewart U; Altmannsberger M; Mannherz HG; Steinhoff M Histochemistry; 1991; 95(4):341-9. PubMed ID: 2022486 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Ramaekers F; Huysmans A; Moesker O; Kant A; Jap P; Herman C; Vooijs P Lab Invest; 1983 Sep; 49(3):353-61. PubMed ID: 6193333 [TBL] [Abstract][Full Text] [Related]
24. Antibodies to intermediate filament proteins. The differential diagnosis of cutaneous tumors. Miettinen M; Lehto VP; Virtanen I Arch Dermatol; 1985 Jun; 121(6):736-41. PubMed ID: 2408582 [TBL] [Abstract][Full Text] [Related]
25. Effects of olfactory bulbectomy, melatonin, and/or pinealectomy on three sublines of the Dunning R3327 rat prostatic adenocarcinoma. Toma JG; Amerongen HM; Hennes SC; O'Brien MG; McBlain WA; Buzzell GR J Pineal Res; 1987; 4(3):321-38. PubMed ID: 3625464 [TBL] [Abstract][Full Text] [Related]
26. Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model. Carter HB; Coffey DS J Urol; 1988 Jul; 140(1):173-5. PubMed ID: 3379685 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumours. Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC Vet Q; 1993 Sep; 15(3):96-102. PubMed ID: 7505511 [TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical study of keratin-positive cells in human prostatic cancer]. Kitajima K; Saitoh N; Kawata N; Okada K Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1045-50. PubMed ID: 2481762 [TBL] [Abstract][Full Text] [Related]
29. Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors. Isaacs JT; Isaacs WB; Coffey DS Cancer Res; 1979 Jul; 39(7 Pt 1):2652-9. PubMed ID: 445468 [TBL] [Abstract][Full Text] [Related]
30. Changes in keratin expression during the development of benign prostatic hyperplasia. Xue Y; Smedts F; Umbas R; Aalders TW; Debruyne FM; de la Rosette JJ; Schalken JA Eur Urol; 1997; 32(3):332-8. PubMed ID: 9358223 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: normal mammary tissue. Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC Vet Q; 1993 Sep; 15(3):102-7. PubMed ID: 7505509 [TBL] [Abstract][Full Text] [Related]
32. Genetic instability assessed by sister chromatid exchange analysis in the Dunning R-3327 rat prostatic adenocarcinoma model and its relationship to metastatic potential. Sharief Y; Mohler JL Prostate; 1995 May; 26(5):247-52. PubMed ID: 7753709 [TBL] [Abstract][Full Text] [Related]
33. Intermediate filament expression in astrocytic neoplasms. Cosgrove M; Fitzgibbons PL; Sherrod A; Chandrasoma PT; Martin SE Am J Surg Pathol; 1989 Feb; 13(2):141-5. PubMed ID: 2464954 [TBL] [Abstract][Full Text] [Related]
34. Is renal cell (Grawitz) tumor a carcinosarcoma? Evidence from analysis of intermediate filament types. Herman CJ; Moesker O; Kant A; Huysmans A; Vooijs GP; Ramaekers FC Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(1):73-83. PubMed ID: 6195807 [TBL] [Abstract][Full Text] [Related]
35. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Okada H; Tsubura A; Okamura A; Senzaki H; Naka Y; Komatz Y; Morii S Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):157-61. PubMed ID: 1381129 [TBL] [Abstract][Full Text] [Related]
36. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines. Tieva A; Bergh A; Damber JE Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703 [TBL] [Abstract][Full Text] [Related]
37. Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer. Isaacs JT; Hukku B Prostate; 1988; 13(2):165-88. PubMed ID: 3174494 [TBL] [Abstract][Full Text] [Related]
38. Expression of transforming growth factor-beta 1 in prostate cancer. Steiner MS; Zhou ZZ; Tonb DC; Barrack ER Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Verhagen AP; Aalders TW; Ramaekers FC; Debruyne FM; Schalken JA Prostate; 1988; 13(1):25-38. PubMed ID: 2458583 [TBL] [Abstract][Full Text] [Related]
40. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor. Isaacs JT; Yu GW; Coffey DS Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]